Lakewood-Amedex completes $1.27M Series C Preferred Stock redemption
Lakewood-Amedex Biotherapeutics Inc. redeemed all outstanding Series C Convertible Preferred Stock for $1.27M from cash on hand, eliminating potential dilution and associated financing restrictions prior to testing.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed